Braga Antônio, Coutinho Lohayne, Chagas Marcela, Soares Juliana Pereira, Callado Gustavo Yano, Alevato Raphael, Lozoya Consuelo, Sun Sue Yazaki, Araujo Júnior Edward, Rezende-Filho Jorge
Department of Gynecology and Obstetrics, School of Medicine, Federal University of Rio de Janeiro (UFRJ), Rua das Laranjeiras, No. 180, Laranjeiras, Rio de Janeiro 22240-003, RJ, Brazil.
Department of Maternal and Child Health, Postgraduate Program in Medical Sciences, School of Medicine, Fluminense Federal University (UFF), Niterói 24070-090, RJ, Brazil.
Diagnostics (Basel). 2025 Aug 4;15(15):1953. doi: 10.3390/diagnostics15151953.
Molar pregnancy (MP) is a gestational disorder resulting from abnormal fertilization, leading to atypical trophoblastic proliferation and the formation of a complete or partial hydatidiform mole. This condition represents the most common form of gestational trophoblastic disease (GTD) and carries a significant risk of progression to gestational trophoblastic neoplasia (GTN). Although rare in high-income countries, MP remains up to ten times more prevalent in low-income and developing countries, contributing to preventable maternal morbidity and mortality. This narrative review provides an updated, practical overview of the clinical presentation, diagnosis, treatment, and follow-up of MP. A key focus is the challenge of early diagnosis, particularly given the increasing frequency of first-trimester detection, where classical histopathological criteria may be subtle, leading to diagnostic errors. The review innovates by integrating advanced diagnostic methods-combining histopathology, immunohistochemistry using p57Kip2, Ki-67, and p53 markers, along with cytogenetic analysis-to improve diagnostic accuracy in early gestation. The central role of referral centers is also emphasized, not only in facilitating timely treatment and access to chemotherapy, but also in implementing standardized post-molar follow-up protocols that reduce progression to GTN and maternal mortality. By focusing on both advanced diagnostic strategies and the organization of care through referral centers, this review offers a comprehensive, practice-oriented perspective to optimize patient outcomes in GTD and address persistent care gaps in high-burden regions.
葡萄胎(MP)是一种由异常受精导致的妊娠疾病,会引起非典型滋养层细胞增殖,并形成完全性或部分性葡萄胎。这种情况是妊娠滋养细胞疾病(GTD)最常见的形式,具有发展为妊娠滋养细胞肿瘤(GTN)的重大风险。尽管在高收入国家中较为罕见,但葡萄胎在低收入和发展中国家的患病率仍然高出多达十倍,这导致了可预防的孕产妇发病和死亡。本叙述性综述提供了关于葡萄胎临床表现、诊断、治疗及随访的最新实用概述。一个关键重点是早期诊断的挑战,特别是考虑到孕早期检测频率的增加,此时经典组织病理学标准可能不明显,从而导致诊断错误。该综述通过整合先进的诊断方法进行创新,将组织病理学、使用p57Kip2、Ki-67和p53标记物的免疫组织化学以及细胞遗传学分析相结合,以提高早孕诊断的准确性。还强调了转诊中心的核心作用,不仅在于促进及时治疗和获得化疗,还在于实施标准化的葡萄胎后随访方案,以减少发展为GTN和孕产妇死亡的情况。通过关注先进的诊断策略以及通过转诊中心进行的护理组织,本综述提供了一个全面的、以实践为导向的视角,以优化GTD患者的治疗结果,并解决高负担地区持续存在的护理差距。